Ignite Creation Date:
2024-07-17 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06500403
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-07-08
Brief Title:
Non-invasive Tools for PSVD Diagnosis
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Study Overview
Official Title:
Noninvasive Tools for the Diagnosis of Porto-sinusoidal Vascular Disease a Single-center Prospective Cohort Study
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients treated with platinum-based chemotherapy drugs have the probability of developing PSVD The diagnosis of PSVD depends on liver biopsy In addition the level of portal vein pressure has guiding value in the diagnosis and prognosis of PSVD Many studies have shown that liver and spleen stiffness have high accuracy in diagnosis and prognosis The purpose of this study is to evaluate the efficacy of the combination of liver and spleen stiffness in the diagnosis of PSVD and to search for effective biomarkers for the diagnosis of PSVD through a single-center prospective observational study
Detailed Description:
PSVD is a supplement to non-cirrhotic portal hypertension and is defined as a class of diseases with characteristic pathological changes based on portal vein or hepatic sinuses abnormalities without cirrhosis Some patients treated with platinum-based chemotherapy drugs will develop PSVD which is clinically manifested as portal hypertension related complications The diagnosis of PSVD depends on liver biopsy In addition the level of portal vein pressure has guiding value in the diagnosis and prognosis of PSVD However liver biopsy and pressure measurement are invasive methods Many studies have shown that liver and spleen stiffness have high accuracy in diagnosis and prognosis The purpose of this study is to evaluate the efficacy of the combination of liver and spleen stiffness in the diagnosis of PSVD and to search for effective biomarkers for the diagnosis of PSVD through a single-center prospective observational study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None